Abstract
The inventor of LSD, Albert Hoffmann, himself referred to his most famous discovery as his ‘problem child’. In the first part of this chapter, we outline the past regulatory, ethical and political issues that surrounded this much researched and debated agent until it ended up as a Schedule I substance, falling under the strictest regulations worldwide. We believe that the ethical, legal and political aspects are equally important to understand what had led to decade-long loss of interest in experimentation on human subjects with LSD. Having explored these issues, we turn our attention to the present research landscape and the future challenges and prospects of trials with this substance. We focus mainly on the research and bioethics aspects; besides we make some explanatory remarks on the past and present political and cultural/socio-critical perspectives that shaped and still affect public and professional discourse on the subject matter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hofmann A (1983) LSD, my problem child: reflections on sacred drugs, mysticism, and science. J.P. Tarcher, Los Angeles
Dyck E (2015) Flashback: psychiatric experimentation with LSD in historical perspective. Can J Psychiatry 50(7):381–388
Novak SJ (2004) LSD before Leary: Sidney Cohen’s critique of 1950s psychedelic drug research. In: Tracy SW, Acker CJ (eds) Altering American consciousness: the history of alcohol and drug use in the United States, 1800–2000. University of Massachusetts Press, Amherst, pp 87–110
Stoll W (1947) Lysergsäure-diäthyl-amid, ein Phantastikum aus der Mutterkorngruppe. Schweiz Arch Neur 60:1–2
Grinspoon L, Bakalar BJ (1981) The psychedelic drug therapies. Curr Psychiatr Ther 20:275–283
Bodnar KJ, Kakuk P (2019) Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review. Med Health Care Philos 22:327–337. https://doi.org/10.1007/s11019-018-9871-9
Pollan M (2015) The trip treatment. New Yorker
Bonson KR (2018) Regulation of human research with LSD in the United States (1949–1987). Psychopharmacology 235:591–604. https://doi.org/10.1007/s00213-017-4777-4
Hagenbach D, Werthmuller L (2011) Mystic chemist: the life of Albert Hofmann and his discovery of LSD. Synergetic Press, Santa Fe
Dyck E (2015) LSD A new treatment emerging from the past, psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ 187(14):1079–1080
Das S, Barnwal P, Ramasamy A, Sen S, Mondal S (2016) Lysergic acid diethylamide: a drug of ‘use’? Ther Adv in Psychopharmacol 6(3):214–228 https://doi.org/10.1177/2045125316640440
Passie T (1997) Psycholytic and psychedelic therapy research 1931–1995: a complete international bibliography. Laurentius Publishers, Hannover
Oram M (2014) Efficacy and enlightenment: LSD psychotherapy and the Drug Amendments of 1962. J Hist Med Allied Sci 69(2):221–250
Oram M (2016) Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration. Hist Psychiatry 27(3):290–306
Fuentes JJ, Fonseca F, Elices M, Farré M, Torrens M (2020) Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials. Front Psych 10:943. https://doi.org/10.3389/fpsyt.2019.00943
Luoma JB, Chwyl C, Bathje GJ, Davis AK, Lancelotta R (2020) A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. J Psychoactive Drugs 52(4):289–299. https://doi.org/10.1080/02791072.2020.1769878
Oram M (2018) The trials of psychedelic therapy LSD psychotherapy in America. John Hopkins University Press, Baltimore
Kurland AA, Unger S, Shaffer JW, Savage C (1967) Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report. Am J Psychiatry 123(10):1202–1209. https://doi.org/10.1176/ajp.123.10.1202
Olson DE (2020) The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci 4(2):563–567. https://doi.org/10.1021/acsptsci.0c00192
Richert L, Dyck E (2020) Psychedelic crossings: American mental health and LSD in the 1970s. Med Humanit 46:184–191
Sessa B (2018) The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant. Psychopharmacology 235(2):551–560. https://doi.org/10.1007/s00213-017-4713-7
Zutshi V (2018) The political significance of LSD. https://www.opendemocracy.net/en/transformation/political-significance-of-lsd/. Accessed 10 May 2021
Gilbert J (2017) Psychedelic socialism, OpenDemocracy
Dean M, Zamora D (2021) The last man takes LSD foucault and the end of revolution. Verso, London
Wade S (2019) Foucault in California. Heyday, New York
Lyons T, Carhart-Harris RL (2018) Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. J Psychopharmacol 32(7):811–819. https://doi.org/10.1177/0269881117748902
Nour MN, Evans L, Robin LC-H (2017) Psychedelics, personality and political perspectives. J Psychoactive Drugs 49(3):182–191. https://doi.org/10.1080/02791072.2017.1312643
Paton M (2015) RD Laing: was the counterculture’s favourite psychiatrist a dangerous renegade or a true visionary. https://www.independent.co.uk/life-style/health-and-families/rd-laing-was-the-counterculture-s-favourite-psychiatrist-a-dangerous-renegade-or-a-true-visionary-a6755021.html. Accessed 10 May 2021
Mashour GA (2007) From LSD to the IRB: Henry Beecher’s psychedelic research and the foundation of clinical ethics. Int Anesthesiol Clin 45(4):105–111
Haave P, Pedersen W (2020) The promise and demise of LSD psychotherapy in Norway. Soc Hist Med. https://doi.org/10.1093/shm/hkz128
Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) Self-blinding citizen science to explore psychedelic microdosing. elife 10:e62878. https://doi.org/10.7554/eLife.62878
Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci 10:269. https://doi.org/10.3389/fnhum.2016.00269
Leonard A (2015) How LSD microdosing became the hot new business trip rolling stone. https://www.rollingstone.com/culture/culture-news/how-lsd-microdosing-became-the-hot-new-business-trip-64961/. Accessed 10 May 2021
Nye C (2017) Microdosing: the people taking LSD with their breakfast. https://www.bbc.com/news/health-39516345. Accessed 10 May 2021
Smith WR, Sisti D (2020) Ethics and ego dissolution: the case of psilocybin. J Med Ethics. Published Online First: 27 May. https://doi.org/10.1136/medethics-2020-106070
Johnson MW, Yaden DB (2020) There’s no good evidence that psychedelics can change your politics or religion. Scientific American
Nutt D (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376(9752):1558–1565
Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol (6):603–620. https://doi.org/10.1177/0269881108093587
Pilecki B, Luoma JB, Bathje GJ (2021) Ethical and legal issues in psychedelic harm reduction and integration therapy. Harm Reduct J 18:40. https://doi.org/10.1186/s12954-021-00489-1
Nutt D, Carhart-Harris R (2021) The current status of psychedelics in psychiatry. JAMA Psychiat 78(2):121–122. https://doi.org/10.1001/jamapsychiatry.2020.2171
Osmond H, Siegler M (1973) Notes on orthomolecular psychiatry and psychotherapy. Orthomolecul Psychiat 2, 3:120, 118–126
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bodnar, K.J., Peter, S. (2022). Regulatory, Ethical and Political Challenges of Experimentation with LSD on Human Subjects. In: Faintuch, J., Faintuch, S. (eds) Integrity of Scientific Research. Springer, Cham. https://doi.org/10.1007/978-3-030-99680-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-99680-2_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-99679-6
Online ISBN: 978-3-030-99680-2
eBook Packages: Social SciencesSocial Sciences (R0)